Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.680
+0.090 (3.47%)
Nov 5, 2024, 1:16 PM EST - Market open
Protara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 55 | 21 | 30 | 76 | 271 | - | |
Market Cap Growth | 58.47% | -29.43% | -60.18% | -72.06% | - | - | |
Enterprise Value | -31 | -47 | -70 | -55 | 106 | - | |
Last Close Price | 2.59 | 1.88 | 2.68 | 6.75 | 24.21 | - | |
PE Ratio | - | -0.53 | -0.46 | -1.60 | -5.15 | - | |
PB Ratio | 0.58 | 0.31 | 0.30 | 0.47 | 1.36 | - | |
P/FCF Ratio | -1.28 | -0.57 | -1.14 | -2.16 | -11.17 | - | |
P/OCF Ratio | -1.29 | -0.57 | -1.14 | -2.20 | -11.60 | - | |
EV/EBITDA Ratio | 0.16 | 1.09 | 1.88 | 1.16 | -3.10 | - | |
EV/EBIT Ratio | 0.16 | 1.08 | 1.87 | 1.16 | -3.09 | - | |
EV/FCF Ratio | 0.21 | 1.25 | 2.64 | 1.57 | -4.38 | - | |
Debt / Equity Ratio | 0.05 | 0.08 | 0.06 | 0.04 | 0.01 | - | |
Debt / FCF Ratio | -0.15 | -0.15 | -0.24 | -0.21 | -0.04 | - | |
Quick Ratio | 15.86 | 10.70 | 14.78 | 21.37 | 57.84 | 0.17 | |
Current Ratio | 16.33 | 11.17 | 15.01 | 21.66 | 58.13 | 0.23 | |
Return on Equity (ROE) | -45.90% | -47.44% | -49.96% | -26.17% | -34.48% | -591.11% | |
Return on Assets (ROA) | -28.11% | -28.36% | -16.42% | -15.80% | -21.07% | -143.64% | |
Return on Capital (ROIC) | -29.39% | -29.91% | -16.90% | -16.07% | -21.72% | -369.45% | |
Earnings Yield | -76.15% | -189.67% | -218.41% | -62.30% | -12.52% | - | |
FCF Yield | -62.55% | -176.45% | -88.01% | -46.28% | -8.95% | - | |
Buyback Yield / Dilution | -22.64% | -0.64% | -0.24% | -55.28% | -180.66% | 76.99% | |
Total Shareholder Return | -22.64% | -0.64% | -0.24% | -55.28% | -180.66% | 76.99% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.